Decoding polygenic diseases: advances in noncoding variant prioritization and validationIris M. Chin, M. Ryan Corces, Zachary A. Gardell|Trends in Cell Biology|2024Cited by 9
<i>APOE</i> *4 risk‐modifying genes and drug targets in Alzheimer's disease through cell‐type‐specific genomic analysesYoujie Zeng, Michaël E. Belloy, Zachary A. Gardell et al.|Alzheimer s & Dementia|2026Cited by 1
Decoding common and rare noncoding variant effects across cellular and developmental contextsAndrew R. Marderstein, Stephen B. Montgomery, Soumya Kundu et al.|Nature Genetics|2026Cited by 0